Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a result, patients with T1D must closely monitor their blood glucose (BG) ...
BACKGROUND: The FINE-CKD model was developed to estimate the cost-effectiveness of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). OBJECTIVE: To perform internal ...